A -284.62% Or Greater Growth Is Projected For Allena Pharmaceuticals Inc. (NASDAQ: ALNA) – Marketing Sentinel
Home  »  Company   »  A -284.62% Or Greater Growth Is Projected For Alle...

A -284.62% Or Greater Growth Is Projected For Allena Pharmaceuticals Inc. (NASDAQ: ALNA)

During the last session, Allena Pharmaceuticals Inc. (NASDAQ:ALNA)’s traded shares were 248.55 million, with the beta value of the company hitting 1.98. At the end of the trading day, the stock’s price was $0.13, reflecting an intraday gain of 70.51% or $0.05. The 52-week high for the ALNA share is $1.45, that puts it down -1015.38 from that peak though still a striking 46.15% gain since the share price plummeted to a 52-week low of $0.07. The company’s market capitalization is $11.73M, and the average intraday trading volume over the past 10 days was 7.35 million shares, and the average trade volume was 2.71 million shares over the past three months.

Allena Pharmaceuticals Inc. (ALNA) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 1.50. ALNA has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.16.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Allena Pharmaceuticals Inc. (NASDAQ:ALNA) trade information

Allena Pharmaceuticals Inc. (ALNA) registered a 70.51% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 70.51% in intraday trading to $0.13 this Thursday, 05/12/22, hitting a weekly high. The stock’s 5-day price performance is 23.72%, and it has moved by -41.87% in 30 days. Based on these gigs, the overall price performance for the year is -88.33%. The short interest in Allena Pharmaceuticals Inc. (NASDAQ:ALNA) is 2.98 million shares and it means that shorts have 2.3 day(s) to cover.

The consensus price target of analysts on Wall Street is $0.50, which implies an increase of 74.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $0.50 and $0.50 respectively. As a result, ALNA is trading at a discount of -284.62% off the target high and -284.62% off the low.

Allena Pharmaceuticals Inc. (ALNA) estimates and forecasts

Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 33.30% this quarter and then jump 23.80% in the quarter after that.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 9.70%. While earnings are projected to return 29.10% in 2022.

ALNA Dividends

Allena Pharmaceuticals Inc. is due to release its next quarterly earnings between March 07 and March 11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Allena Pharmaceuticals Inc. (NASDAQ:ALNA)’s Major holders

Allena Pharmaceuticals Inc. insiders own 1.65% of total outstanding shares while institutional holders control 23.73%, with the float percentage being 24.12%. AIGH Capital Management LLC is the largest shareholder of the company, while 40 institutions own stock in it. As of Sep 29, 2021, the company held over 4.0 million shares (or 4.84% of all shares), a total value of $3.61 million in shares.

The next largest institutional holding, with 3.33 million shares, is of Frazier Management LLC’s that is approximately 4.03% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $3.0 million.

Also, the Mutual Funds coming in first place with the largest holdings of Allena Pharmaceuticals Inc. (ALNA) shares are Fidelity Select Portfolios – Biotechnology and Vanguard Total Stock Market Index Fund. Data provided on Oct 30, 2021 indicates that Fidelity Select Portfolios – Biotechnology owns about 2.3 million shares. This amounts to just over 2.78 percent of the company’s overall shares, with a $1.91 million market value. The same data shows that the other fund manager holds slightly less at 1.43 million, or about 1.74% of the stock, which is worth about $1.29 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts